Answers are grounded in this paper and cite their sources.
A 77-year-old male patient initially presented with annular infiltrative erythema on the face 4 years prior (Figure 1), without pruritus or pain. He was diagnosed with dermatitis in the dermatology department and treated with topical medications. Two years later, asymptomatic small papules developed on the left forearm, which he neglected. Subsequently, progressive numbness, weakness, and tenderness in bilateral forearms, hands, and feet prompted an internal medicine consultation, where “diabetic peripheral neuropathy” was suspected. Concurrently, eyebrow and eyelash loss/thinning emerged but were overlooked. Eight months before presentation, scattered pruritic papules and nodules (erythematous to skin-colored) appeared on the face (Figure 2) and neck. Past medical history included type 2 diabetes mellitus. Systemic examination revealed no significant abnormalities. Dermatological findings included sparse eyebrows/eyelashes, generalized erythematous plaques/papules/nodules on the face, neck, and upper limbs (some with central ulceration/crusting), and scattered dark-red papules with hyperpigmentation on the back and buttocks. No palpable thickening or tenderness of superficial nerves was noted. No sensory loss or ocular involvement was observed. Skin biopsies from his face and neck were done(Figure 3a–c). Histopathological examination of both biopsies demonstrated epidermal atrophy with flattened rete ridges. Dermal involvement featured a Grenz zone, dense spindle-shaped histiocytic infiltration surrounded by collagenous pseudocapsules, abundant foam cells, and neural invasion (Figure 3). Acid-fast staining showed strong positivity with abundant mycobacterium leprae clusters (Figure 4). Skin slit smear: Acid-fast bacilli (AFB) density: left orbital 5+, right orbital 5+, mandibular 5+, facial lesion 6+, left upper limb 6+; Bacteriological Index (BI) 5.4. The histopathological features confirmed histoid leprosy. Classified as lepromatous leprosy under traditional Ridley-Jopling criteria, the patient was treated by multibacillary combination chemotherapy regimen (MB-MDT), which consisted of once-monthly rifampicin and daily aminoglycol and clofazimine, and was treated for 6 months. Fazimine, at follow-up after 6 months of treatment, the patient's skin lesions subsided compared to before, and the skin of the face and both upper limbs showed hyperpigmentation without other adverse reactions. Leprosy is a chronic infectious disease caused by the bacterium Mycobacterium leprae that mainly affects the skin and peripheral nerves. Leprosy can be transmitted through close and frequent contact with untreated cases [1], and according to the weekly report of the World Health Organization (WHO), 140,594 new cases were reported globally in 2021, with more than half of them in the Southeast Asian region (66%) [2]. Histoid leprosy (HL) is an uncommon clinicopathological variant of Hansen's disease, characterized by distinct immunological, clinical histological and bacteriological features. It is regarded as an intensified form of multibacillary leprosy, marked by an enhanced cellular and humoral immune response, which accounts for 1.1%–3.6% of all leprosy patients [3]. HL presents clinically as firm cutaneous and subcutaneous papules, plaques, and nodules, mainly on the back, bony prominences, limbs, and face [3, 4], most commonly in patients initially diagnosed with verrucous leprosy, followed by borderline partial verrucous leprosy, intermediate borderline leprosy, and borderline partial tuberculoid leprosy [5]. Histopathology shows epidermal atrophy, nodular infiltration of spindle cells in the dermis, and a large number of resistant bacilli visible on antacid staining [3, 6]. The importance of this variant lies in its high bacillary load, which makes it a potentially significant source of disease transmission if not diagnosed or treated promptly. Although HL is a well-established variant of multibacillary leprosy spectrum, it poses a diagnostic challenge in histopathology because it mimics many dermatological conditions because of tumoriform spindle cell proliferation, such as dermatofibroma and neurofibroma. In a recent study, factor XIIIa (positive in dermatofibromas) and S100 protein (strongly expressed by neurofibromas) were suggested as markers to differentiate HL from the other tumoriform spindle cell lesions [6]. The presence of Mycobacterium leprae and nerve thickening on biopsy or skin smear are the main distinguishing features [1]. Our case was finally diagnosed because of the presence of the classical histopathological and characteristic bacterial morphology, and the presence of a high bacterial index in skin slit smears. Therapeutically the World Health Organization recommends the use of a combination of rifampicin, amiloride and clofazimine multidrug therapy (MDT) for the treatment of leprosy, our patient was an elderly male with underlying disease but no abnormalities in liver or renal function, the skin lesions receded markedly with MDT treatment, and the hyperpigmentation was considered to be caused by clofazimine, and the World Health Organization considers the skin darkening of clofazimine to be an innocuous adverse effect because it is transient, the disappears within a few months after completion of treatment [7]. Whereas some studies have found that this regimen may not be sufficiently effective, pefloxacin and ofloxacin may be good adjuncts to enhance the efficacy of MDT, clofazimine and aminoglutethimide + rifampicin can be used for the treatment of type 2 leprosy reactions, and monotherapy regimens are not sufficient to effectively treat leprosy, polymicrobial leprosy or type 2 leprosy reactions [8], and the response of this patient to therapy is still being follow-up. Although rarely fatal, leprosy may be associated with nerve damage, tissue destruction and loss of function. Early diagnosis and timely initiation of treatment may be important factors in reducing morbidity [9], and early detection and adequate treatment may reduce the number of cases and eliminate possible sequelae of leprosy [10]. Qian Ding: writing – original draft preparation. Qin-Si Liu: investigation, supervision. Heng-Guang Zhao: conceptualization, writing – reviewing and editing. This study was supported by grants from the National Natural Science Foundation of China (82173440, 82473555 and 82304058), Natural Science Foundation of Chongqing (cstc2021jcyj-msxmX0955). All patients in this manuscript have given written informed consent for participation in the study and the use of their deidentified, anonymized, aggregated data and their case details (including photographs) for publication. Ethical approval: not applicable. The authors declare no conflicts of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: